Cefstar Injection 250mg

About Cefstar Injection 250mg

Cefstar Injection 250mg Uses

• Treats mild to moderate urinary tract infections
• Used for lower respiratory tract infections in less severe cases
• Manages uncomplicated skin and soft tissue infections
• Prescribed for paediatric patients needing weight-based cefepime dosing
• Used as a step-down option after higher-dose therapy improves
• Helps treat infections in patients with reduced kidney function needing a lower dose

Cefstar Injection 250mg Benefits

• Broad-spectrum action against many gram-positive and gram-negative bacteria
• Lower strength allows flexible dosing for children and smaller adults
• Fast bacterial clearance due to injectable route bypassing gut absorption issues
• Useful in patients who cannot tolerate oral antibiotics
• Supports safer dosing in patients with mild renal impairment
• Reduces risk of overdosing in low-body-weight patients

What Experts Say

Physicians favour the 250mg cefepime vial when a full adult dose is not clinically needed, particularly in paediatric care or in adults with early, less severe infections. The lower strength allows precise weight-based dosing without splitting a larger vial, which reduces preparation errors in hospital and clinic settings.

Cefepime remains active against many Pseudomonas and Enterobacteriaceae strains, and doctors often choose it when local resistance patterns favour a fourth-generation cephalosporin over older agents. Renal function is checked before dosing since cefepime clears mainly through the kidneys, and the 250mg strength is frequently selected for patients with mild renal impairment where a reduced dose is appropriate.

Pakistan carries a high burden of hospital-acquired infections needing injectable antibiotics, and physicians recommend cefepime when first-line agents show resistance on culture reports. Neurotoxicity signs are monitored in renal-impaired patients even at this lower dose, since accumulation can occur with repeated dosing.

Drug Class

• Fourth-generation cephalosporin
• Beta-lactam antibiotic

Cefstar Injection 250mg formula

• Cefepime 250mg

Available forms

• Injection

How to use Cefstar Injection 250mg?

• Given only by a trained healthcare provider as an intravenous or intramuscular injection
• Typical paediatric dosing is calculated by body weight and prescribed by the treating doctor
• Reconstituted with the diluent provided or as instructed by the pharmacist
• Administered slowly over the time period advised by the healthcare team
• Dose and frequency depend on infection type and kidney function
• Complete the full prescribed course even if symptoms improve early
• Report any swelling, rash or breathing difficulty at the injection site immediately

Drug Interactions

• Aminoglycosides: Combined use may increase the risk of kidney toxicity.
• Furosemide and other loop diuretics: Concurrent use can raise the chance of kidney damage.
• Probenecid: May slow elimination of cefepime, raising drug levels in the blood.
• Live bacterial vaccines: Antibiotic therapy may reduce vaccine effectiveness.
• Other nephrotoxic drugs: Combined use increases the overall risk of kidney injury.

Risks and warnings

• Kidney function: Dose adjustment is needed in patients with reduced kidney function to avoid drug buildup.
• Allergy history: Avoid use in patients with a known allergy to cephalosporins or penicillins.
• Seizure risk: Higher accumulation from missed dose adjustments can raise the risk of seizures, especially in renal impairment.
• Paediatric use: Dosing must be calculated precisely by weight in children and infants.
• Pregnancy and breastfeeding: Use only if the treating doctor confirms the benefit outweighs any risk.
• Superinfection: Prolonged use may lead to overgrowth of resistant bacteria or fungal infection.
• Injection site reaction: Pain, redness or swelling can occur and should be reported.
• Diarrhoea: Severe or persistent diarrhoea during or after treatment needs prompt medical review.

Cefstar Injection 250mg Side Effects

• Pain or redness at the injection site
• Nausea
• Diarrhoea
• Vomiting
• Skin rash
• Headache
• Fever
• Itching
• Vein inflammation at the infusion site
• Abnormal liver enzyme levels
• Low blood cell counts in rare cases
• Confusion or seizures in patients with kidney impairment

Storage Conditions

• Store the unopened vial at room temperature, away from direct sunlight
• Keep below 25°C in a cool, dry place
• Use the reconstituted solution promptly as advised by the pharmacist
• Discard any unused reconstituted solution after the recommended time
• Keep out of reach of children